Life Sciences

The lab, located at 260 Cedar Hill St., will serve as a hub for the company’s research efforts as it works to convert carbon dioxide into degradable, high-performance polymers.

The company says the deal will allow customers to source a comprehensive range of precision tools from a single source, saving time and simplifying the procurement process.

The report comes less than a week after the Supreme Court ruled that the Trump administration can slash nearly $800 million in National Institutes of Health funding.

Lifeward had a second executive join its C-suite transition in two months as the Marlborough-based medical device has selected its new CFO.

Lifeward mobility products will be available in six new countries following the company's expanded partnership with its England-based distributor. 

MBI’s SPARK program is a free eight-week opportunity pairing aspiring entrepreneurs with mentors from MBI’s network to help the startups overcome certain obstacles.

Jim Green will retire from his roles as chairman, president, and CEO of Harvard Bioscience on July 28.

The deal, announced in a Monday press release, seeks to accelerate Waters’ expansion into high-growth markets and deliver cost and revenue synergies.

The project will involve other site improvements, including the construction of outdoor patios, landscape improvements. A portion of Research Drive will be relocated to segregate pedestrian and truck traffic.

After months of negotiations, including those with an anonymous, unsolicited third party, Marlborough-based biotech firm Akoya Biosciences has officially been acquired by Quanterix.